If a clinician recommends combining sermorelin and ipamorelin , it should come with: a clear rationale (what problem is being treated), a monitoring plan (often IGF-1 and metabolic markers), and explicit stop rules for side effects
The Lancet 390 (10093), 521530
and the National Research, Development and Innovation Fund of the Ministry of Culture and Innovation, under the National Laboratories Program (National Tumor Biology Laboratory, 20222.1.1-NL-2022-00010) and the Hungarian Thematic Excellence Program (project TKP2021-EGA-44) to P.N
The key is understanding that weight maintenance is not only about the medication itself
Is something like that even possible
However, long-term studies have established that Semaglutide is generally safe, with many of the side effects improving as treatment continues